Last reviewed 2026-04-23 · How we verify

CHI-554

Canopy Growth Corporation · Phase 2 active Small molecule

At a glance

Generic name	CHI-554
Sponsor	Canopy Growth Corporation
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety of Co-Administered CHI-554 and Alcohol (PHASE1)
CBD in Postmenopausal Women With Osteopenia (PHASE1)
A Randomized Controlled Test of the Effects of CHI-554 on Fear. (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results